最新更新 :
04/03/2025
Infostab
薬剤一覧
まとめ一覧
互換性の検索
Yサイト対応表
引用文献
研究チーム
valistab
ポスター
接続
スポンサー
作成者
ユーザーガイド
ニュースレター
Ganciclovir sodium
化学構造
商品名
商品名、賦形剤は国、製薬会社ごとに異なることがあります
Ceptyl
メキシコ
Ciganclor
アルゼンチン
Citovirax
イタリア
Cymevan
フランス
Cymeven
ドイツ
Cymevene
アイスランド, アイルランド, アラブ首長国連邦, アーストラリア, イギリス, イタリア, イラン, エクアドル, エジプト, オランダ, オーストリア, ギリシア, クロアチア, コロンビア, スイス, スウェーデン, スペイン, チリ, デンマーク, トルコ, ニュージーランド, ノルウェー, ハンガリー, フィンランド, ブラジル, ベネズエラ, ベルギー, ペルー, ポルトガル, ポーランド, マレーシア, メキシコ, ルクセンブルグ, ロシア
Cymevir
ブラジル
Cytovene
アメリカ, カナダ
Ganciclovir
アメリカ, アルゼンチン, エクアドル, カナダ, チリ, ドイツ, フランス, メキシコ
Gavir
インド
Inglav
メキシコ
Natclovir
インド
Pharcigave
メキシコ
Umecortil
コロンビア, メキシコ
Viraprex
メキシコ
引用文献 : Ganciclovir sodium
形式
出版物
3
雑誌
Trissel LA, Martinez JF.
Compatibility of amifostine with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 2208-2212.
4
雑誌
Zazempa V, Morgenszejn J, Paul M, Astier A.
Reconstitution centralisée du ganciclovir : méthode de contrôle et étude de stabilité.
Act Pharm Biol Clin 1995 ; 8: 525-528.
36
雑誌
Alex S, Gupta SL, Minor JR, Turcovski-Corrales S, Gallelli JF, Taub D, Piscitelli SC.
Compatibility and activity of aldesleukin (recombinant interleukin-2) in presence of selected drugs during simulated Y-site administration: Evaluation of three methods.
Am J Health-Syst Pharm 1995 ; 52: 2423-2426.
59
雑誌
Trissel LA, Gilbert DL, Martinez JF, Kim MC.
Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 2192-2196.
67
雑誌
Outman WR, Mitrano FP, Baptista RJ.
Visual compatibility of ganciclovir sodium and parenteral nutrient solution during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 1538-1539.
69
雑誌
Visor GC, Lin LH, Jackson SE, Winterle JS, Lee G, Kenley RA.
Stability of ganciclovir sodium (DHPG sodium) in 5% dextrose or 0.9% sodium chloride injections.
Am J Hosp Pharm 1986 ; 43: 2810-2812.
70
雑誌
Silvestri AP, Mitrano FP, Baptista RJ, Williams DA.
Stability and compatibility of ganciclovir sodium in 5% dextrose injection over 35 days.
Am J Hosp Pharm 1991 ; 48: 2641-2643.
72
雑誌
Johnson CE, Jacobson PA, Chan E.
Stability of ganciclovir sodium and amino acids in parenteral nutrient solutions.
Am J Hosp Pharm 1994 ; 51: 503-508.
73
雑誌
Lor E, Takagi J.
Visual compatibility of foscarnet with other injectable drugs.
Am J Hosp Pharm 1990 ; 47: 157-159.
74
雑誌
Mulye NV, Turco SJ, Speaker TJ.
Stability of ganciclovir sodium in an infusion-pump syringe.
Am J Hosp Pharm 1994 ; 51: 1348-1349.
76
雑誌
Parasrampuria J, Li LC, Stelmach AH, Sykes TR, Gordon GA.
Stability of ganciclovir sodium in 5% dextrose injection and in 0.9% sodium chloride injection over 35 days.
Am J Hosp Pharm 1992 ; 49: 116-118.
81
雑誌
Trissel LA, Martinez JF.
Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1994 ; 51: 672-678.
84
雑誌
Trissel LA, Martinez JF.
Visual, turbidimetric, and particle-content assessment of compatibility of vinorelbine tartrate with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1994 ; 51: 495-499.
88
雑誌
Mole L, Oliva C, O?Hanley P.
Extended stability of ganciclovir for outpatient parenteral therapy for cytomegalovirus retinitis.
J Acquired Immune Defic Syndr 1992 ; 5: 354-358.
99
雑誌
Trissel LA, Martinez JF.
Compatibility of aztreonam with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 1086-1090.
169
雑誌
Trissel LA, Martinez JF.
Physical compatibility of melphalan with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1993 ; 50: 2359-2363.
182
雑誌
Trissel LA, Gilbert DL, Martinez JF.
Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 56-60.
201
雑誌
Thompson DF, Allen LV, Stiles ML.
Visual compatibility of enalaprilate with selected intravenous medications during simulated Y-site injection.
Am J Hosp Pharm 1990 ; 47: 2530-2531.
244
雑誌
Trissel LA, Martinez JF.
Compatibility of filgrastim with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1907-1913.
245
雑誌
Phaypradith S, Vigneron J, Perrin A, Durney-Archeray MJ, Hoffman MA, Hoffman M.
Stability of ganciclovir sodium (Cymevan*) after dilution in PVC infusions and polypropylene syringes.
J Pharm Belg 1992 ; 47: 494-498.
248
雑誌
Trissel LA, Martinez JF.
Turbidimetric assessment of the compatibility of taxol with 42 other drugs during simulated Y-site injection.
Am J Hosp Pharm 1993 ; 50: 300-304.
249
雑誌
Trissel LA, Martinez JF.
Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1996 ; 53: 1041-1045.
251
雑誌
Trissel LA, Gilbert DL, Martinez JF.
Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 2708-2713.
253
雑誌
Trissel LA, Chandler SW, Folstad JT.
Visual compatibility of amsacrine with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1990 ; 47: 2525-2528.
299
雑誌
Trissel LA, Martinez JF, Gilbert DL.
Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1735-1741.
300
雑誌
Trissel LA, Gilbert DL, Martinez JF.
Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1287-1292.
301
雑誌
Trissel LA, Gilbert DL, Martinez JF, Baker MB, Walter WV, Mirtallo JM.
Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1295-1300.
307
雑誌
Trissel LA, Martinez JF.
Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration.
Am J Hosp Pharm 1994 ; 51: 1792-1799.
334
雑誌
Trissel LA, Tramonte SM, Grilley BJ.
Visual compatibility of ondansetron hydrochloride with selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 988-992.
335
雑誌
Trissel LA, Bready BB, Kwan JW, Santiago NM.
Visual compatibility of sargramostim with selected antineoplasic agents, anti-infectives, or other drugs during simulated Y-site injection.
Am J Hosp Pharm 1992 ; 49: 402-406.
479
雑誌
Min DI, Brown T, HWang GC.
Visual compatibility of tacrolimus with commonly used drugs during simulated Y-site injection.
Am J Hosp Pharm 1992 ; 49: 2964-2966.
492
雑誌
Trissel LA, Parks NPT, Santiago NM.
Visual compatibility of fludarabine phosphate with antineoplastic drugs, anti-infectives, and other selected drugs during simulated Y-site injection.
Am J Hosp Pharm 1991 ; 48: 2186-2189.
496
雑誌
Lor E, Sheybani T, Takagi J.
Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration.
Am J Hosp Pharm 1991 ; 48: 744-746.
604
実験
Stabilité des médicaments dans l'Intermate® SV50, 100, 200
Baxter 1998
905
雑誌
Trissel LA, Martinez JF.
Screening teniposide for Y-site physical incompatibilities.
Hosp Pharm 1994 ; 29: 1010-1017.
921
雑誌
Trissel LA, Gilbert DL, Martinez JF.
Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during simulated Y-site administration.
Hosp Pharm 1998 ; 33: 284-292.
1410
雑誌
Trissel LA, Martinez JF, Simmons M.
Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 141-145.
1415
雑誌
Trissel L.A, Gilbert D.L, Martinez J.F, Baker M.B, Walter W.V, Mirtallo J.M.
Compatibility of medications with 3-in-1 parenteral nutrition admixtures.
JPEN 1999 ; 23: 67-74.
1423
雑誌
Trissel LA, Martinez JF, Gilbert DL.
Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 514-518.
1625
雑誌
Trissel LA, Saenz C, Williams YW, Ingram D.
Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2001 ; 5: 314-321.
1754
雑誌
Trissel LA, Gilbert DL, Wolkin AC.
Compatibility of docetaxel with selected drugs during simulated Y-site administration.
Int J Pharm Compound 1999 ; 3: 241-244.
1925
雑誌
Trissel LA , Williams KY, Gilbert DL.
Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
J Am Pharm Assoc 2000 ; 40: 515-519.
1953
雑誌
Trissel LA, Saenz CA, Ogundele AB, Ingram DS.
Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
1982
雑誌
Trissel LA, Ogundele AB.
Compatibility of anidulafungin with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2005 ; 62: 834-837.
2247
雑誌
Chan P, Heatherly K, Kupiec T.C, Trissel L.A.
Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2008 ; 12, 3: 276-278.
3626
実験
Tacrolimus (Prograf®) - Résumé des Caractéristiques du Produit
Astellas Pharma 2014
3662
実験
Foscavir (Foscarnet®) - Summary of Product Characteristics
Clinigen 2014
3728
雑誌
Correard F, Savry A, Gauthier-Villano L, Pisano P, Pourroy B.
Visual compatibility of defibrotide with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2014 ; 71: 1288-1291.
3791
ポスター
Sadou Yaye H, Burtet E, Hamel C, Aljhni R, Gard C, Tilleul P.
Étude de la compatibilité physico-chimique du phloroglucinol injectable durant les mélanges au sein des tubulures en Y.
Apifh Congress, Paris November 2014 2014
3796
雑誌
Morlet N, Young S, Naidoo D et al.
High dose intravitreal ganciclovir for CMV retinitis: a shelf life and cost comparison study.
Br Ophtalmol 1995 ; 79: 753-755.
3883
実験
Ceftazidime - Résumé des caractéristiques du produit
Arrow 2016
4021
雑誌
Guichard N, Bonnabry P, Rudaz S, Fleury S.
Long-term stability of ganciclovir in polypropylene containers at room temperature.
J Oncol Pharm Practice 2017 ;25,2: 303-308
4521
雑誌
Polo C, D’Huart E, Lesperlette G, Vigneron J, Meyer F, Demoré B.
Compatibility of injectable posaconazole with drugs commonly used in a hematology care unit.
Pharmaceutical Technology in Hospital Pharmacy 2020
Mentions Légales